Kurs & Likviditet
Kalender
2024-10-31 | Kvartalsrapport 2024-Q3 |
2024-08-16 | Kvartalsrapport 2024-Q2 |
2024-06-05 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2024-06-04 | Årsstämma 2024 |
2024-04-30 | Kvartalsrapport 2024-Q1 |
2024-02-15 | Bokslutskommuniké 2023 |
2023-11-01 | Kvartalsrapport 2023-Q3 |
2023-08-11 | Kvartalsrapport 2023-Q2 |
2023-06-02 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2023-06-01 | Årsstämma 2023 |
2023-05-11 | Kvartalsrapport 2023-Q1 |
2023-02-16 | Bokslutskommuniké 2022 |
2022-11-01 | Kvartalsrapport 2022-Q3 |
2022-08-12 | Kvartalsrapport 2022-Q2 |
2022-06-03 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2022-06-02 | Årsstämma 2022 |
2022-05-10 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-11-04 | Kvartalsrapport 2021-Q3 |
2021-08-13 | Kvartalsrapport 2021-Q2 |
2021-06-04 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2021-06-03 | Årsstämma 2021 |
2021-05-11 | Kvartalsrapport 2021-Q1 |
2021-02-18 | Bokslutskommuniké 2020 |
2020-11-06 | Kvartalsrapport 2020-Q3 |
2020-08-20 | Kvartalsrapport 2020-Q2 |
2020-06-04 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2020-06-03 | Årsstämma 2020 |
2020-05-14 | Kvartalsrapport 2020-Q1 |
2020-03-11 | Extra Bolagsstämma 2020 |
2020-02-13 | Bokslutskommuniké 2019 |
2019-11-01 | Kvartalsrapport 2019-Q3 |
2019-08-23 | Kvartalsrapport 2019-Q2 |
2019-05-29 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2019-05-28 | Årsstämma 2019 |
2019-05-15 | Kvartalsrapport 2019-Q1 |
2019-02-14 | Bokslutskommuniké 2018 |
2018-12-20 | Extra Bolagsstämma 2018 |
2018-11-09 | Kvartalsrapport 2018-Q3 |
2018-08-24 | Kvartalsrapport 2018-Q2 |
2018-06-08 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2018-06-07 | Årsstämma 2018 |
2018-05-30 | Kvartalsrapport 2018-Q1 |
2018-02-15 | Bokslutskommuniké 2017 |
2017-11-10 | Kvartalsrapport 2017-Q3 |
2017-07-28 | Kvartalsrapport 2017-Q2 |
2017-06-07 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2017-06-06 | Årsstämma 2017 |
2017-05-10 | Kvartalsrapport 2017-Q1 |
2017-02-15 | Bokslutskommuniké 2016 |
2017-01-13 | Extra Bolagsstämma 2017 |
2016-11-11 | Kvartalsrapport 2016-Q3 |
2016-08-18 | Kvartalsrapport 2016-Q2 |
2016-06-21 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2016-06-20 | Årsstämma 2016 |
2016-05-11 | Kvartalsrapport 2016-Q1 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-10-30 | Extra Bolagsstämma 2015 |
2015-10-30 | Kvartalsrapport 2015-Q3 |
2015-08-21 | Kvartalsrapport 2015-Q2 |
2015-06-09 | X-dag ordinarie utdelning NAVA 0.00 NOK |
2015-06-08 | Årsstämma 2015 |
2015-04-28 | Kvartalsrapport 2015-Q1 |
2015-02-27 | Bokslutskommuniké 2014 |
2014-10-31 | Kvartalsrapport 2014-Q3 |
2014-08-22 | Kvartalsrapport 2014-Q2 |
2014-06-10 | Årsstämma 2014 |
2014-05-06 | Kvartalsrapport 2014-Q1 |
2014-02-27 | Bokslutskommuniké 2013 |
2013-11-01 | Kvartalsrapport 2013-Q3 |
2013-08-30 | Kvartalsrapport 2013-Q2 |
2013-06-13 | Kapitalmarknadsdag 2013 |
2013-05-23 | Årsstämma 2013 |
2013-04-25 | Kvartalsrapport 2013-Q1 |
2013-02-15 | Bokslutskommuniké 2012 |
2012-02-10 | Bokslutskommuniké 2011 |
2011-10-21 | Kvartalsrapport 2011-Q3 |
2011-08-25 | Kvartalsrapport 2011-Q2 |
2011-05-05 | Kvartalsrapport 2011-Q1 |
2011-04-14 | Årsstämma 2011 |
2011-02-04 | Bokslutskommuniké 2010 |
2010-10-28 | Kvartalsrapport 2010-Q3 |
2010-08-26 | Kvartalsrapport 2010-Q2 |
2010-05-05 | Kvartalsrapport 2010-Q1 |
2010-03-25 | Årsstämma 2010 |
2010-02-11 | Bokslutskommuniké 2009 |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Oslo, 7 October 2020: Reference is made to Navamedic ASA's (the "Company") stock exchange announcement published on 30 September 2020 regarding the board of directors' resolution to increase the Company's share capital in connection with the exercise of employee share options.
The share capital increase pertaining to the exercised share options has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The new share capital of the Company is NOK 11,315,994.90, divided into 15,291,885 shares, each with a par value of NOK 0.74.
Following the registration of the new shares in the Norwegian Central Securities Depository (the VPS), which is expected to take place today, the new shares will be delivered to the subscriber and listed on the Oslo Stock Exchange.
For further information, please contact:
Lars Hjarrand, CFO, Navamedic,
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com
About Navamedic
Navamedic ASA is a preferred, full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com
This information is published pursuant to the continuing obligations of the Oslo Stock Exchange.